Bendamustine plus rituximab is an effective first-line treatment in hairy cell leukemia variant: a report of three cases.
| Image |  |
|---|---|
| Description | scientific article published on 28 September 2017 |
| Author/s |
author: Federica Frezzato Livio Trentin Andrea Visentin Andrea Visentin Francesco Piazza |
| Publication date | September 28, 2017 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |